March 20, 2023 Watch on YouTube. Transcript Hi, I’m Lanie Bachmann. The human ability to recognize facial expressions is fundamental to social communication. During social interactions, we use the facial expressions of others to better understand how they’re feeling. Given their importance, it makes sense that emotional expressions facilitate attention better than faces without emotional…
March 20, 2023 Watch on YouTube. Transcript Hi there. My name is Abby Vogeley, and today I’ll be presenting on long-term observation of participants with treatment-resistant mood disorders. Treatment-resistant depression, or TRD, is commonly defined as failing at least two antidepressant treatment trials and is thought to afflict between 15 to 30% of those with…
March 23, 2023 • Research Highlight The Medicaid program, administered by the Centers for Medicare and Medicaid Services, provides health coverage to millions of Americans, including eligible low-income adults, children, pregnant women, elderly adults, and people with disabilities. As the program is a state-federal partnership, its implementation can vary widely across states. A new study…
He’s still on the throne. In moments when rough waves rock the boat of our Christian lives, an otherwise near-platitude can be a welcomed reminder. Our God is sovereign. Whatever befalls his people has been lovingly sifted through his fingers. Our trials and troubles are no evidence of his abdication or defeat, but of his…
The US Food and Drug Administration (FDA) has granted Wesper, a sleep testing and management service provider, clearance for its next-generation home sleep testing device, which allows for clinical-grade longitudinal data collection over multiple nights to diagnose, titrate, and monitor treatment efficacy over time. According to a press release by Wesper, the new device reduces…
For women with multiple sclerosis who report cognitive dysfunction—one of the most common and disabling symptoms of the disease—sleep disorders such as insomnia and sleep apnea may contribute to the perceived decline, a Michigan Medicine study suggests. Researchers analyzed data from over 60,000 women using the 2013 and 2017 waves of the Nurses’ Health Study,…
By Risa Kerslake, BSN-RN An international team led by Stephany Fulda, PhD, a sleep researcher and clinician at the sleep medicine unit of the Neurocenter of Southern Switzerland, has carried out a large systematic review and meta-analysis to assess the accuracy of screening instruments in their ability to diagnose restless legs syndrome (RLS) in 52…
The US Food and Drug Administration (FDA) has approved Pre-Launch Activities Importation Requests (PLAIR) for Avadel Pharmaceuticals’ Lumryz (sodium oxybate), a tentatively-approved drug to treat cataplexy or excessive daytime sleepiness in adults with narcolepsy. Avadel is now authorized to import the unapproved drug product into the US ahead of its anticipated final approval to prepare…